Small molecule · Antagonist of histamine H1 receptor (HRH1) · developed by Delcor Asset
ApprovedFDA, Mar 1951
1Registered trials
What is Promethazine?
Promethazine is a phenothiazine derivative that antagonizes histamine H1 receptors and binds muscarinic receptors, producing antihistaminic, anticholinergic and antiemetic effects. It has been studied for nausea and vomiting in patients with hepatic impairment, including hepatic coma in hepatitis C.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.